Authors:
Inoue, Y
Yagisawa, M
Saeki, K
Imajoh-Ohmi, S
Kanegasaki, S
Yuo, A
Citation: Y. Inoue et al., Induction of phagocyte oxidase components during human myeloid differentiation: Independent protein expression and discrepancy with the function, BIOS BIOT B, 65(11), 2001, pp. 2581-2584
Authors:
Yamauchi, A
Yu, LX
Potgens, AJG
Kuribayashi, F
Nunoi, H
Kanegasaki, S
Roos, D
Malech, HL
Dinauer, MC
Nakamura, M
Citation: A. Yamauchi et al., Location of the epitope for 7D5, a monoclonal antibody raised against human flavocytochrome b(558), to the extracellular peptide portion of primate gp91(phox), MICROB IMMU, 45(3), 2001, pp. 249-257
Authors:
Ishibashi, F
Mizukami, T
Kanegasaki, S
Motoda, L
Kakinuma, R
Endo, F
Nunoi, H
Citation: F. Ishibashi et al., Improved superoxide-generating ability by interferon gamma due to splicingpattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene, BLOOD, 98(2), 2001, pp. 436-441
Authors:
Kitamura, T
Uchida, K
Tanaka, N
Tsuchiya, T
Watanabe, J
Yamada, Y
Hanaoka, K
Seymour, JF
Schoch, OD
Doyle, I
Inoue, Y
Sakatani, M
Kudoh, S
Azuma, A
Nukiwa, T
Tomita, T
Katagiri, M
Fujita, A
Kurashima, A
Kanegasaki, S
Nakata, K
Citation: T. Kitamura et al., Serological diagnosis of idiopathic pulmonary alveolar proteinosis, AM J R CRIT, 162(2), 2000, pp. 658-662
Authors:
Ishibashi, F
Nunoi, H
Endo, F
Matsuda, I
Kanegasaki, S
Citation: F. Ishibashi et al., Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency, HUM GENET, 106(5), 2000, pp. 473-481
Authors:
Nunoi, H
Yamazaki, T
Tsuchiya, H
Kato, S
Malech, HL
Matsuda, I
Kanegasaki, S
Citation: H. Nunoi et al., A heterozygous mutation of beta-actin associated with neutrophil dysfunction and recurrent infection, P NAS US, 96(15), 1999, pp. 8693-8698
Authors:
Kitamura, T
Tanaka, N
Watanabe, J
Uchida, K
Kanegasaki, S
Yamada, Y
Nakata, K
Citation: T. Kitamura et al., Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor, J EXP MED, 190(6), 1999, pp. 875-880
Authors:
Tanaka, N
Watanabe, J
Kitamura, T
Yamada, Y
Kanegasaki, S
Nakata, K
Citation: N. Tanaka et al., Lungs of patients with idiopathic pulmonary alveolar proteinosis express afactor which neutralizes granulocyte-macrophage colony stimulating factor, FEBS LETTER, 442(2-3), 1999, pp. 246-250
Citation: Jh. Cho et al., Activation of human neutrophils by a synthetic anti-microbial peptide, KLKLLLLLKLK-NH2, via cell surface calreticulin, EUR J BIOCH, 266(3), 1999, pp. 878-885
Authors:
Tsuchiya, T
Imajoh-Ohmi, S
Nunoi, H
Kanegasaki, S
Citation: T. Tsuchiya et al., Uncompetitive inhibition of superoxide generation by a synthetic peptide corresponding to a predicted NADPH binding site in gp91-phox, a component ofthe phagocyte respiratory oxidase, BIOC BIOP R, 257(1), 1999, pp. 124-128
Authors:
Iwata, M
Nunoi, H
Matsuda, I
Kanegasaki, S
Tsuruo, T
Sugimoto, Y
Citation: M. Iwata et al., Drug-selected complete restoration of superoxide generation in Epstein-Barr virus-transformed B cells from p47(phox)-deficient chronic granulomatous disease patients by using a bicistronic retrovirus vector encoding a human multi-drug resistance gene (MDR1) and the p47(phox) gene, HUM GENET, 103(4), 1998, pp. 419-423